Infection with GB virus C (GBV-C) in patients with chronic liver disease or on maintenance hemodialysis in Indonesia

Journal of Medical Virology

Volumn 49, Issue 3, 1996, Pages 248-252

  Tsuda, Fumio ^a   Hadiwandowo, Soeliadi ^b   Sawada, Naoto ^c   Fukuda, Masako ^c   Tanaka, Takeshi ^d   Okamoto, Hiroaki ^e   Miyakawa, Yuzo ^f   Mayumi, Makoto ^e  

^a Shinagawa ku   (Japan)

^b GADJAH MADA UNIVERSITY   (Indonesia)

^c Institute of Immunology Co Ltd   (Japan)

^d JAPANESE RED CROSS SOCIETY   (Japan)

^e JICHI MEDICAL UNIVERSITY   (Japan)

^f Miyakawa Memorial Research Foundation   (Japan)

Author keywords

blood transfusion; chronic hepatitis; epidemiology; hemodialysis; hepatitis B virus; hepatitis C viruses; hepatitis viruses

Indexed keywords

COMPLEMENTARY DNA; HELICASE; VIRUS RNA;

ADULT; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HEPATITIS C VIRUS; HEPATITIS VIRUS; HEPATITIS VIRUS NON A NON B; HUMAN; INDONESIA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS CHARACTERIZATION; VIRUS TRANSMISSION;

ANTIGENS, VIRAL; BASE SEQUENCE; CHRONIC DISEASE; DNA HELICASES; DNA, VIRAL; FLAVIVIRIDAE; HEPACIVIRUS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C ANTIBODIES; HEPATITIS, VIRAL, HUMAN; HUMANS; INDONESIA; LIVER DISEASES; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RENAL DIALYSIS; RNA, VIRAL; SEQUENCE HOMOLOGY, NUCLEIC ACID;

GB VIRUS C/HEPATITIS G VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; NON A NON B HEPATITIS VIRUS; NON-A, NON-B HEPATITIS VIRUS; RNA VIRUSES;

EID: 0029785617     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199607)49:3<248::AID-JMV15>3.0.CO;2-8     Document Type: Article

References (23)

1. Aikawa T, Sugai Y, Okamoto H (1996): Hepatitis G infection in drug abusers with chronic hepatitis C (correspondence). New England Journal of Medicine 334:195-196.
2. Alter HJ, Bradley DW (1995): Non-A, non-B hepatitis unrelated to the hepatitis C virus (non-ABC). Seminars in Liver Disease 15:110-120.
3. Alter MJ, Hadler SC, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Moyer LA, Fields HA, Bradley DW, Margolis HS (1990): Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. Journal of the American Medical Association 264:2231-2235.
4. Brettler DB, Alter HJ, Dienstag JL, Forsberg AD, Levine PH (1990): Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients. Blood 76:254-256.
5. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989): Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
6. Deinhardt F, Holmes AW, Capps RB, Popper H (1967): Studies on the transmission of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passages, and description of liver lesions. Journal of Experimental Medicine 125:673-688.
7. Egawa K, Yukawa T, Arakawa S, Nakao H, Inoue T, Tanaka T, Tsuda F, Okamoto H, Miyakawa Y, Mayumi M (1996): Infection with hepatitis GB virus C in leprous patients in Japan. Journal of Medical Virology, in press.
8. Fagan EA, Harrison TJ (1994): Exclusion in liver by polymerase chain reaction of hepatitis B and C viruses in acute liver failure attributed to sporadic non-A, non-B hepatitis. Journal of Hepatology 21: 587-591.
9. Hadiwandowo S, Tsuda F, Okamoto H, Tokita H, Wang Y, Tanaka T, Miyakawa Y, Mayumi M (1994): Hepatitis B virus subtypes and hepatitis C virus genotypes in patients with chronic liver disease or on maintenance hemodialysis in Indonesia. Journal of Medical Virology 43:182-186.
10. Houghton M, Weiner A, Han J, Kuo G, Choo QL (1991): Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 14:381-388.
11. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee WS, Kuo C, Berger D, Shuster JR, Overby LR, Bradley DW, Houghton M (1989): An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362-364.
12. Linnen J, Wages J, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, Koonin E, Gallagher M., Alter M, Hadziyannis S, Karayiannis P, Fung K, Nakatsuji Y, Shih JWK, Young L, Piatak M, Hoover C, Fernandez J, Chen S, Zou JC, Morris T, Hyams KC, Ismay S, Lifson JD, Hess G, Foung SKH, Thomas H, Bradley D, Margolis H, Kim JP (1996): Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 271:505-508.
13. Mutimer D, Shaw J, Neuberger J, Skidmore S, Martin B, Hubscher S, McMaster P, Elias E (1995): Failure to incriminate hepatitis B, hepatitis C, and hepatitis E viruses in the aetiology of fulminant non-A non-B hepatitis. Gut 36:433-436.
14. Okamoto H, Okada S, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y, Machida A, Mishiro S, Yoshizawa H, Miyakawa Y, Mayumi M (1990): Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Japanese Journal of Experimental Medicine 60:215-222.
15. Okamoto H, Mishiro S, Tokita H, Tsuda F, Miyakawa Y, Mayumi M (1994): Superinfection of chimpanzees carrying hepatitis C virus of genotype II/1b with that of genotype III/2a or I/1a. Hepatology 20:1131-1136.
16. Schleuder GG, Dawson GJ, Simons JN, Pilot-Matias TJ, Gutierrez RA, Heynen CA, Knigge MF, Kurpierwski GS, Buijk SL, Leary TP, Muerhoff AS, Desai SM, Mushahwar IK (1995): Molecular and serologic analysis in the transmission of the GB hepatitis agents. Journal of Medical Virology 46:81-90.
17. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, Desai SM, Mushahwar IK (1995a): Isolation of novel virus-like sequences associated with human hepatitis. Nature Medicine 1:564-569.
18. Simons JN, Pilot-Matias TJ, Leary TP, Dawson GJ, Desai SM, Schlauder GG, Muerhoff AS, Erker JC, Buijk SL, Chalmers ML, Van Sant CL, Mushahwar IK (1995b): Identification of two flavivirus-like genomes in the GB hepatitis agent. Proceedings of the National Academy of Sciences USA 92:3401-3405.
19. van der Poel C, Reesink HW, Lelie PN, Leentvaar KA, Choo QL, Kuo G, Houghton M (1989): Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands. Lancet ii:297-298.
20. Weiner AJ, Kuo G, Bradley DW, Bonino F, Saracco G, Lee C, Rosenblatt J, Choo QL, Houghton M (1990): Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet 335:1-3.
21. Wright TL (1993): Etiology of fulminant hepatic failure: is another virus involved? Gastroenterology 104:640-643.
22. Yoshiba M, Okamoto H, Mishiro S (1995): Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 346:1131-1132.
23. Zuckerman AJ (1995): The new GB hepatitis viruses. Lancet 345: 1453-1454.